Evaluation of biological responders after interferon therapy with chronic hepatitis C.

被引：0
|
作者：
Tanaka, M [1 ]
Nishiguchi, S [1 ]
Enomoto, M [1 ]
Tanaka, T [1 ]
Minamitani, S [1 ]
Fukuda, K [1 ]
Tamori, A [1 ]
Habu, D [1 ]
Takeda, T [1 ]
Shiomi, S [1 ]
Seki, S [1 ]
Kuroki, T [1 ]
机构：
[1] Osaka City Univ, Sch Med, Osaka 545, Japan
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
158
引用
收藏
页码：200A / 200A
页数：1
相关论文
共 50 条
  • [1] Interferon/ribavirin treatment in interferon non-responders with chronic hepatitis C.
    Teuber, G
    Berg, T
    Leidig, L
    Hoffmann, RM
    Lafrenz, M
    Spengier, U
    Hopf, U
    Zeuzem, S
    HEPATOLOGY, 1998, 28 (04) : 375A - 375A
  • [2] A comparison of combination therapy with interferon and ribavirin vs interferon and amantadine in interferon non-responders with chronic hepatitis C.
    Khalili, M
    Olmeda, M
    Denham, CB
    Perrillo, RP
    HEPATOLOGY, 1998, 28 (04) : 169A - 169A
  • [3] Combination therapy with interferon α and β to chronic hepatitis C.
    Horilke, N
    Michitaka, K
    Masumoto, T
    Yamamoto, K
    Yamauchi, Y
    Kojima, N
    Onjl, M
    HEPATOLOGY, 1998, 28 (04) : 373A - 373A
  • [4] Histological response of interferon therapy in chronic hepatitis C.
    Segawa, T
    Moriyama, M
    Shibahara, N
    Kaneko, M
    Suzuki, K
    Tanaka, N
    Okubo, H
    Ishizuka, H
    Arakawa, Y
    Sugitani, M
    Suzuki, K
    Uchida, T
    Shikata, T
    GASTROENTEROLOGY, 1997, 112 (04) : A1378 - A1378
  • [5] Breakthrough and interferon dose in the therapy of chronic hepatitis C.
    Bellati, G
    Roffi, L
    Colloredo, G
    DAcquino, M
    Ricci, A
    Redaelli, A
    Tempini, S
    Bellobuono, A
    Bonino, F
    Ideo, G
    HEPATOLOGY, 1996, 23 (01) : P97 - P97
  • [6] Changes in hypervariable region 1 after interferon therapy of patients with chronic hepatitis C.
    Tanaka, M
    Nishiguchi, S
    Enomoto, M
    Kuroooka, H
    Minamitani, S
    Fukuda, K
    Tamori, A
    Habu, D
    Takeda, T
    Shiomi, S
    Otani, S
    Todo, N
    HEPATOLOGY, 2000, 32 (04) : 355A - 355A
  • [7] Long-term outcome after interferon therapy in patients with chronic hepatitis C.
    Buti, Maria
    Esteban, Rafael
    ANNALS OF HEPATOLOGY, 2007, 6 (04) : 267 - 269
  • [8] Changes of HGV RNA titer during and after interferon therapy in chronic hepatitis C.
    Segawa, T
    Moriyama, M
    Shibahara, N
    Kasuya, A
    Iwaguchi, K
    Ichijima, S
    Iwasaki, H
    Matsumura, H
    Shimizu, T
    Tanaka, N
    Okubo, H
    Ishizuka, H
    Arakawa, Y
    Abe, K
    HEPATOLOGY, 1997, 26 (04) : 1884 - 1884
  • [9] Factors determining efficacy of interferon therapy for chronic hepatitis C.
    Shioda, A
    Moriyama, M
    Komine, F
    Suzuki, K
    Tanaka, N
    Okubo, H
    Ishizuka, H
    Arakawa, Y
    GASTROENTEROLOGY, 1996, 110 (04) : A1323 - A1323
  • [10] Interferon and glycyrrhizin combined therapy in the treatment of chronic hepatitis C.
    Naito, M
    Kashiwagi, T
    Tsutsumi, H
    Nagasawa, M
    Toyama, T
    Tanaka, Y
    Ito, A
    Ozaki, S
    Ishibashi, K
    Azuma, M
    HEPATOLOGY, 1996, 23 (01) : P189 - P189
12345